PKM and hepatocellular carcinoma: In HCC, the dysregulation of two specific glycolytic enzymes known as hexokinase 2 (HK2) and pyruvate kinase M2 (PKM2) allows this metabolic switch required for hepatocyte proliferation and partly for tumorigenesis6.